1 / 58
文档名称:

pad指南解读ppt课件.ppt

格式:ppt   大小:2,072KB   页数:58页
下载后只包含 1 个 PPT 格式的文档,没有任何的图纸或源代码,查看文件列表

如果您已付费下载过本站文档,您可以点这里二次下载

分享

预览

pad指南解读ppt课件.ppt

上传人:992006838 2021/2/20 文件大小:2.02 MB

下载得到文件列表

pad指南解读ppt课件.ppt

相关文档

文档介绍

文档介绍:周围动脉疾病治疗指南
解 读
1
Class I Benefit >>> Risk
Procedure/ Treatment SHOULD be performed/ administered
Class IIa Benefit >> Risk Additional studies with focused objectives needed
IT IS REASONABLE to perform procedure/administer treatment
Class IIb Benefit ≥ Risk Additional studies with broad objectives needed; Additional registry data would be helpful
Procedure/Treatment
MAY BE CONSIDERED
Class III
Risk ≥ Benefit No additional studies needed
Procedure/Treatment should NOT be performed/administered SINCE IT IS NOT HELPFUL AND MAY BE HARMFUL
should
is recommended
is indicated
is useful/effective/ beneficial
is reasonable
can be useful/effective/ beneficial
is probably recommended or indicated
may/might be considered
may/might be reasonable
usefulness/effectiveness is unknown /unclear/uncertain or not well established
is not recommended
is not indicated
should not
is not useful/effective/beneficial
may be harmful
推荐级别及证据分级
2
Class I Benefit >>> Risk
Procedure/ Treatment SHOULD be performed/ administered
Class IIa Benefit >> Risk Additional studies with focused objectives needed
IT IS REASONABLE to perform procedure/administer treatment
Class IIb Benefit ≥ Risk Additional studies with broad objectives needed; Additional registry data would be helpful
Procedure/Treatment
MAY BE CONSIDERED
Class III
Risk ≥ Benefit No additional studies needed
Procedure/Treatment should NOT be performed/administered SINCE IT IS NOT HELPFUL AND MAY BE HARMFUL
Level B 单中心随机对照研究;或非随机性研究
推荐级别及证据分级
Level A 经过多中心随机对照研究得到的一致性结论
Level C 无随机对照研究的专家共识或制定的治疗规范。
3
危险因素
PAD主要病因是动脉粥样硬化。
导致动脉粥样硬化的危险因素包括(吸烟、糖尿病、血脂异常、高血压、高同型半胱氨酸血症、C反应蛋白升高)
4
危险因素
5
高危人群
年龄大于70岁
年龄大于50,小于70岁,有糖尿病或吸烟史
年龄小于50岁,患糖尿病,同时合并(吸烟史;血脂异常;高血压;高同型半胱氨酸血症)任一危险因素
既往有冠脉、脑血管或肾血管动脉硬化病史
6
自然病程
Limb
Morbidity
Cardiovascular Morbidity / Mortality
Worsening Claudication 10-20%
Critical Limb Ischemia
1-2%
Nonfatal CV Events
20%
Mortality 15-30%